VentureBeat

Posts Tagged ‘co:youtorrent’

Here’s the latest action:

Big layoffs at Sitoa? — San Mateo-based Sitoa has laid off approximately 40 out of 70 employees in order to get to breakeven, we’ve heard from a source. The company has tens of millions in revenues, but fees are only 10% so the company has always operated in the red. They have been trying to raise more money. Positioned as an e-commerce solution provider that gives retailers access to more products without worrying about inventory, Sitoa is having (or rumored to have) its own inventory problems due to high rates of returns and shrinkage. They have a handful of clients; Sears is one of them. There have recently been a flurry of LinkedIn updates and recommendations among remaining and former employees.

Power issue knocks GrandCentral offline — The online phone company which Google bought last year was down for most of this morning, TechCrunch reports. While the company blames a power outage on the service going down, it speaks to a larger issue as more everyday services move online — what happens if one of these services goes down? With traditional phone services, if there was a bad storm, you might lose service and understand why. With a server power issue happening in the middle of nowhere, the service can go down and you don’t even know it — you just don’t get your calls. Find our recent coverage on Grand Central here and here.

Google TV ads close to launching for the public — The service, which is currently in a closed trials, will allow anyone to buy advertising time on television stations that have a deal with Google (including A&E, Bravo, CNN, others) through Dish Network, according to Multichannel News. While much is made about of an overall shift to online advertising, Google knows how big of a business advertising on television still is, and is looking to transfer its success online to TV. The public should be able to use the service in the next few weeks.

AdMob’s March mobile metrics data — The mobile advertising company says it served over 2.85 billion ad requests last month. Clearly, the mobile advertising market is healthy. Nokia lost some of the mobile marketing share while companies like Motorola, RIM (makers of the Blackberry device) and Apple (makers of the iPhone) rose. We previously wrote about AdMob’s statistics here. You can access the report here.

Torrent searching site YouTorrent looking to sell — The popular torrent (a file transfered online, usually by way of many users) searching site has decided to clean up its act — it will now only index and search sites which host torrents, meaning most copyrighted material will be left out. The site, which has over 10 million unique visitors a month, hopes this move will allow it to be sold, TorrentFreak reports.

TODAY’S HEADLINES:

stemline-logo-150px.gifStemline Therapeutics, cancer stem-cell startup, gets $13M – New York-based Stemline Therapeutics, a biotech focused on new cancer treatments, raised $12.5 million in a funding round. Healthcare funds managed by Pequot Capital Management provided the funding.

Stemline is one of several companies that hope to attack cancer by taking aim at cancer “stem cells,” which are thought to give rise to tumors the same way embryonic stem cells develop into the body’s 200+ types of tissue. One theory holds that conventional cancer chemotherapy often fails because while it can kill huge numbers of tumor cells, it tends to miss the stem cells that can migrate through the body and spark metastatic tumor growth.

Stemline already has one experimental drug against acute myeloid leukemia in early stage clinical trials, although it licensed that drug from the Texas A&M Health Science Center rather than discovering the molecule itself. The startup reports eight other drug candidates at an earlier stage of development.

Stemline has so far been overshadowed by the much flashier OncoMed, another cancer stem-cell startup that  last December struck a partnership with GlaxoSmithKline potentially worth $1.4 billion. It’s not clear, though, whether OncoMed has actually begun clinical trials of its leading drug candidate yet.

Eye-disease biotech Potentia Pharma raises $12M – Potentia Pharmaceuticals, a Louisville, Ky., biotech focused on eye diseases of the elderly, raised $12 million in an unspecified funding round. Backers include HealthCare Ventures and MASA Life Science Ventures.

Potentia hopes to treat a blinding disorder known as age-related macular degeneration by reducing inflammation. Specifically, the startup’s lead drug candidate, POT-4, inhibits the complement system, an arm of the body’s immune defenses that may be responsible for much of the damage associated with AMD.

Sample-prep toolmaker Arcxis aims for $8M to $10M – Pleasanton, Calif.-based Arcxis Biotechnologies, a maker of systems that prepare biological samples for analysis, hopes to raise $8 million to $10 million in a second funding round, VentureWire reports. The company raised $6.5 million in its first funding round, which took place in three installments from August 2006 through February 2008.

CORRECTION: An earlier version of this item incorrectly stated that Arcxis raised $11.1 million in February and wrongly attributed that fact to VentureWire. Arcxis CEO Howard Goldstein emailed me with the correct numbers.

Top Stories

Recent Comments

Powered by Disqus

Featured Guest Columnists

Job Board

Links

Venturebeat Writers

  • For advertising, contact .
  • Log in

Font Size